Yubero-Serrano, Elena MPerez-Martinez, Pablo2023-02-082023-02-082020-04-03Yubero-Serrano EM, Pérez-Martínez P. Advanced Glycation End Products and Their Involvement in Cardiovascular Disease. Angiology. 2020 Sep;71(8):698-700http://hdl.handle.net/10668/15315Circulating levels and tissue accumulation of advanced glyca-tion end products (AGEs) are strongly linked with metabolicimbalance and the progression of chronic diseases, includingcardiovascular disease (CVD). 1,2 Diet is the most importantexogenous source of AGEs contributing to the total body AGEsload. Experimental and clinical evidence suggests that thereduction in body AGE content, by dietary AGE restriction,could modulate different pathways involved in the pathophy-siology of CVDenAdvanced glycation end productsCardiovascular diseasesDietCardiovascular diseasesDietDiet, healthyDiet, mediterraneanGlycation end products, advancedHumansProtective factorsReceptor for advanced glycation end productsRisk assessmentRisk factorsRisk reduction behaviorSignal transductionresearch article32242451Conducta de reducción del riesgoDieta mediterráneaEnfermedades cardiovascularesMedición de riesgoProductos finales de glicación avanzadaReceptor para productos finales de glicación avanzadaTransducción de señal10.1177/00033197209163011940-1574